SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-017576
Filing Date
2011-03-28
Accepted
2011-03-28 16:02:47
Documents
3
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v215421_10k.htm 10-K 1287915
2 v215421_ex31.htm EX-31 18662
3 v215421_ex32.htm EX-32 7475
  Complete submission text file 0001144204-11-017576.txt   1315132
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 000-51476 | Film No.: 11715670
SIC: 2834 Pharmaceutical Preparations